Dietary Supplement OTC Monograph Claims Opposed By CSPI
This article was originally published in The Tan Sheet
Executive Summary
FDA should "modify language" in the structure/ function claims final rule to "prohibit dietary supplements from carrying the same claims as those that are approved for over-the-counter (OTC) drugs," the Center for Science in the Public Interest states in a March 30 citizen petition.